ReviewRegulation of surfactant secretion
Introduction
Lung surfactant consists largely of lipids with phosphatidylcholine (PC) being by far the most abundant component (van Golde et al., 1988, Rooney et al., 1994). More than half of the PC in surfactant is disaturated (Rooney, 1992) and it is disaturated PC that is critical for the biophysical role of surfactant (Keough, 1998). Surfactant also contains four unique proteins: surfactant protein A (SP-A), SP-B, SP-C and SP-D (Kuroki and Voelker, 1994, Johansson and Curstedt, 1997). The type II pneumocyte is the cellular source of surfactant within the lung (van Golde et al., 1988, Wright and Dobbs, 1991, Rooney et al., 1994). The type II cell can synthesize all of the lipid and protein components of surfactant. SP-A, SP-B and SP-D are also synthesized in airway epithelial cells but the extent to which those cells contribute to surfactant production is not clear (Johansson et al., 1994).
Surfactant secretion has been measured in several systems ranging from intact animals in vivo to isolated type II cells in culture (Chander and Fisher, 1990, Wright and Dobbs, 1991, Mason and Voelker, 1998, Rooney, 1998). Isolated type II cells have been the model of choice for most studies on the regulation of surfactant secretion. Studies on surfactant secretion have focused primarily on its lipid components, particularly PC or disaturated PC. Surfactant phospholipids are synthesized in the endoplasmic reticulum and stored in lamellar inclusion bodies, the secretory organelle characteristic of the type II cell, and finally secreted into the alveolar lumen by the process of regulated exocytosis (Mason and Voelker, 1998, Rooney, 1998, Rooney et al., 1994). Lamellar bodies in the process of exocytosis have been captured by electron microscopy (Fig. 1). The phospholipid composition of isolated lamellar bodies is virtually identical to that of surfactant (Rooney, 1992) and it is clear that surfactant phospholipids are secreted together with lamellar bodies (Chander and Fisher, 1990, Wright and Dobbs, 1991, Mason and Voelker, 1998, Rooney, 1998). It is possible that there is also some constitutive secretion of surfactant lipids; the basal secretion of phospholipids that is observed in isolated type II cells cultured without secretagogues may well be a constitutive process.
Secretion of surfactant proteins has been less extensively investigated. Lamellar bodies are enriched in SP-B and SP-C (Oosterlaken-Dijksterhuis et al., 1991) and it is likely that these hydrophobic proteins are secreted together with the phospholipids (Rooney, 1998). Indeed in recent preliminary experiments, we have found that secretion of SP-B and SP-C is stimulated by the surfactant phospholipid secretagogue 12-O-tetradecanoylphorbol-13-acetate (TPA) in primary cultures of adult rat type II cells. Secretion of SP-A appears to be largely constitutive and not regulated (Mason and Voelker, 1998, Rooney, 1998). SP-A secretion in isolated type II cells is not generally stimulated by agonists that stimulate PC secretion (Froh et al., 1993, Rooney et al., 1993, Xu et al., 1998), although in two studies it was stimulated by TPA (Dobbs et al., 1982, Xu et al., 1998). Furthermore, both in vivo (Ikegami et al., 1992, Ikegami et al., 1994) and tissue culture (Osanai et al., 1998) experiments suggest that newly synthesized SP-A is secreted independently of lamellar bodies. Lamellar bodies are devoid of SP-D (Crouch et al., 1991, Voorhout et al., 1992) so that protein must also be secreted independently of the lipids. Indeed secretion of SP-D was not stimulated by TPA or terbutaline in cultured type II cells (Xu et al., 1998). In summary, secretion of surfactant phospholipids and SP-B and SP-C occurs largely by regulated exocytosis of lamellar bodies whereas secretion of SP-A and SP-D occurs by a different mechanism and may be mainly constitutive.
A variety of physiological and pharmacological agents stimulate surfactant PC secretion in isolated type II cells and there are also agents that inhibit it (Chander and Fisher, 1990, Wright and Dobbs, 1991, Mason and Voelker, 1998, Rooney, 1998). Surfactant secretagogues include those that activate cell surface receptors as well as those that penetrate the cell and activate downstream signaling steps (Fig. 2). Well established PC secretagogues in cultured type II cells include β-adrenergic and adenosine A2B receptor agonists, P2Y2 receptor agonists (ATP, UTP), forskolin and cholera toxin that directly or indirectly activate adenylate cyclase (AC), agents such as TPA and cell-permeable diacylglycerols (DAGs) that directly activate protein kinase C (PKC) and ionophores (ionomycin and A23187) that promote Ca2+ influx into the cell (Chander and Fisher, 1990, Wright and Dobbs, 1991, Mason and Voelker, 1998, Rooney, 1998).
Section snippets
Signaling mechanisms of surfactant secretion
A working model of the signal–transduction mechanisms that mediate surfactant secretion is shown in Fig. 2. The signaling mechanisms consist of three distinct pathways although there is overlap and interactions among them (Griese et al., 1993, Rooney, 1998). The first mechanism involves the activation of AC, generation of cyclic AMP (cAMP) and subsequent activation of cAMP-dependent protein kinase (protein kinase A, PKA). This pathway is activated by β-adrenergic and adenosine A2B receptors
Signaling proteins
It is evident that there are several signaling proteins involved in the surfactant secretion signaling pathways. Many subtypes and/or isomers of the receptors and other signaling proteins listed in Fig. 2 are known to exist. There is increasing information on the identity of the specific proteins involved in surfactant secretion. There is evidence that it is the β2, A2B and P2Y2 subtypes of the β-adrenergic, adenosine and P2 receptors, respectively, that regulate surfactant secretion in type II
Other signaling mechanisms
In addition to those discussed, other signaling mechanisms may also be involved in surfactant secretion. For instance, there are data suggesting involvement of phospholipase A2 as well as a PC-specific PLC in ATP and TPA mediated secretion (Rooney, 1998). High- and low-density serum lipoproteins were reported to stimulate PC secretion by activation of receptors coupled via Gi to the PKC signaling mechanism (Voyno-Yasenetskaya et al., 1993, Pian and Dobbs, 1997). Mastoparan, an agent that
Distal steps in surfactant secretion
Distal steps in the surfactant secretory pathway have received little attention. As shown in Fig. 2, all of the signal–transduction pathways are believed to result in phosphorylation of proteins following activation of specific protein kinases. There is virtually no information on the identity of the proteins phosphorylated in response to surfactant secretagogues although TPA (Warburton et al., 1991) and terbutaline (Zimmerman et al., 1996) were reported to promote phosphorylation of a number
Physiological regulation of surfactant secretion
Little is known about physiological regulation of surfactant secretion. β-Agonists (Oyarzun and Clements, 1978, Abdellatif and Hollingsworth, 1980), cholinergic agonists (Oyarzun and Clements, 1977, Abdellatif and Hollingsworth, 1980, Rooney and Gobran, 1988) and adenosine (Ekelund et al., 1985) stimulate surfactant secretion in vivo. However, the mere fact that an agent has an effect in vivo does not establish that it has a physiological role. Blockade of a physiological response, on the other
Acknowledgements
Work in the author's laboratory was supported by grants HL-31175 and HL-43320 from the National Institutes of Health. Previously unpublished data were generated in collaboration with Laurice I. Gobran and Zhi-xin Xu.
References (91)
The protein kinase C inhibitors Ro 318220 and GF 109203X are equally potent inhibitors of MAPKAP kinase-1B (Rsk-2) and p70 S6 kinase
FEBS Letts.
(1997)- et al.
The effect of dexamethasone and prostaglandin F2α on production and release of surfactant in type II alveolar cells
Prostaglandins
(1978) - et al.
The biochemistry of neurotransmitter secretion
J. Biol. Chem.
(1995) - et al.
The selective protein kinase C inhibitor, Ro-31-8220, inhibits mitogen-activated protein kinase phosphatase-1 (MKP-1) expression, induces c-Jun expression, and activates Jun N-terminal kinase
J. Biol. Chem.
(1996) - et al.
The regulation of vascular function by P2 receptors: multiple sites and multiple receptors
Trends Pharmacol. Sci.
(1998) The search for physiological substrates of MAP and SAP kinases in mammalian cells
Trends Cell Biol.
(1997)- et al.
Potent selective inhibitors of protein kinase C
FEBS Letts.
(1989) - et al.
Secretion of surfactant by primary cultures of alveolar type II cells isolated from rats
Biochim. Biophys. Acta
(1982) Phospholipase D
Biochim. Biophys. Acta
(1998)- et al.
A2B adenosine and P2Y2 receptors stimulate mitogen-activated protein kinase in human embryonic kidney-293 cells. Cross-talk between cyclic AMP and protein kinase C pathways
J. Biol. Chem.
(1999)
Functional evidence for involvement of P2 purinoceptors in the ATP stimulation of phosphatidylcholine secretion in type II alveolar epithelial cells
Biochim. Biophys. Acta
Signal-transduction mechanisms of ATP-stimulated phosphatidylcholine secretion in rat type II pneumocytes: interactions between ATP and other surfactant secretagogues
Biochim. Biophys. Acta
Characterization of two alternately spliced forms of phospholipase D1. Activation of the purified enzymes by phosphatidylinositol 4,5-bisphosphate, ADP-ribosylation factor, and Rho family monomeric GTP-binding proteins and protein kinase C-α
J. Biol. Chem.
Diacylglycerols and phosphatidates: which molecular species are intracellular messengers?
Trends Biochem. Sci.
Mechanisms of mastoparan-stimulated surfactant secretion from isolated pulmonary alveolar type 2 cells
J. Biol. Chem.
Cloning, expression, and characterization of a novel phospholipase D complementary DNA from rat brain
J. Biol. Chem.
Pulmonary surfactant proteins
J. Biol. Chem.
Direct demonstration of mechanically induced release of cellular UTP and its implication for uridine nucleotide receptor activation
J. Biol. Chem.
The effect of labor on surfactant secretion in newborn rabbit lung slices
Biochim. Biophys. Acta
Regulatory mechanisms of surfactant secretion
Biochim. Biophys. Acta
Insight into adenosine receptor function using antisense and gene-knockout approaches
Trends Physiol. Sci.
Cloning and characterization of phospholipase D from rat brain
J. Biol. Chem.
SNAREs and the secretory pathway-lessons from yeast
Exp. Cell Res.
Evidence for Gβγ-mediated cross-talk in primary cultures of lung alveolar cells. Pertussis toxin-sensitive production of cAMP
J. Biol. Chem.
Regulation of phosphoinositide-specific phospholipase C isozymes
J. Biol. Chem.
Adenosine and leukotrienes have a regulatory role in lung surfactant secretion in the newborn rabbit
Biochim. Biophys. Acta
Influence of the protein kinase C inhibitor 3-{1-[3-(amidinothio)propyl]-1H-indoyl-3-yl}-3-(1-methyl-1H-indoy l-3-yl)maleimide methane sulfonate (Ro-318220) on surfactant secretion in type II pneumocytes
Biochem. Pharmacol.
Activation of P2Y2 receptors by UTP and ATP stimulates mitogen-activated kinase activity through a pathway that involves related adhesion focal tyrosine kinase and protein kinase C
J. Biol. Chem.
The PLD superfamily: insights into catalysis
Biochim. Biophys. Acta
Diacylglycerol — when is it an intracellular messenger?
Biochim. Biophys. Acta
Identification of PKC-isoform-specific biological actions using pharmacological approaches
Trends Pharmacol. Sci.
Secretagogue-induced proteolysis of cAMP–dependent protein kinase in intact rat alveolar epithelial type II cells
Biochim. Biophys. Acta
Effect of oxotremorine and epinephrine on lung surfactant secretion in neonatal rabbits
Pediatr. Res.
Beta-adrenergic receptors and their regulation
Am. J. Respir. Crit. Care Med.
Regulation of lung surfactant secretion
Am. J. Physiol. Lung Cell. Mol. Physiol.
Surfactant protein D. Increased accumulation in silica-induced pulmonary lipoproteinosis
Am. J. Pathol.
Osmotic stress induces both secretion and apoptosis in rat alveolar type II cells
Am. J. Physiol. Lung Cell. Mol. Physiol.
Release of fetal lung surfactant: effects of xanthines and adenosine
Characterization of the β-adrenergic receptor in isolated human fetal lung type II cells
Pediatr. Res.
Phosphoinositide phospholipases and G proteins in hormone action
Annu. Rev. Physiol.
Interactions of beta adrenergic antagonists with isolated rat alveolar type II pneumocytes. I. Analysis, characterization and regulation of specific beta adrenergic receptors
J. Pharmacol. Exp. Ther.
Stretch increases inositol 1,4,5–trisphosphate concentration in airway epithelial cells
Am. J. Respir. Cell Mol. Biol.
Nomenclature and classification of purinoceptors
Pharmacol. Rev.
Secretion of surfactant protein A and phosphatidylcholine from type II cells of human fetal lung
Am. J. Respir. Cell Mol. Biol.
Adenylate cyclase-coupled ATP receptor and surfactant secretion in type II pneumocytes from newborn rats
Am. J. Physiol. Lung Cell. Mol. Physiol.
Cited by (126)
A comparative study on the influence of an ivy preparation and an ivy/thyme combination on the β<inf>2</inf>-adrenergic signal transduction
2020, HeliyonCitation Excerpt :Physiological mechanisms targeting secretolytic and bronchospasmolytic effects are based on the formation of the second messenger cAMP after stimulation of β2AR in the respiratory tract. cAMP is crucial because it induces both the formation of surfactant in alveolar type 2 cells and a decrease of intracellular calcium concentration in bronchial muscle cells [1, 2, 3]. For the treatment of respiratory tract diseases with mucus covered and narrowed airways drugs are useful, which support these physiological mechanisms.
Lavage lipidomics signatures in children with cystic fibrosis and protracted bacterial bronchitis
2019, Journal of Cystic FibrosisRegulation of Surfactant-Associated Phospholipid Synthesis and Secretion
2017, Fetal and Neonatal Physiology, 2-Volume SetPulmonary surfactant metabolism in the alveolar airspace: Biogenesis, extracellular conversions, recycling
2017, Annals of AnatomyCitation Excerpt :The development of primary ATII cell culture techniques has allowed the study of signaling pathways involved in pulmonary surfactant exocytosis. Many physiological and pharmacological agents, such as β-adrenergic agonists, purinergic agonists (ATP and UTP), cholera toxin, forskolin and ionophores, may stimulate surfactant secretion through activation of signaling mediators such as protein kinase A (PKA), protein kinase C (PKC), and Ca2+/calmodulin-dependent protein kinase (CaMK) (Rooney, 2001). Purinergic-induced regulation of surfactant secretion has been widely characterized.